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The innate immune system safeguards the organism
from both pathogenic and environmental stressors.
Also, physiologic levels of nutrients affect organismal
and intra-cellular metabolism and challenge the im-
mune system. In the long term, over-nutrition leads
to low-grade systemic inflammation. Here, we investi-
gate tissue-resident components of the innate im-
mune system (macrophages) and their response to
short- and long-term nutritional challenges. We
analyze the transcriptomes of six tissue-resident
macrophage populations upon acute feeding and
identify adipose tissue macrophages and the IL-1
pathway as early sensors of metabolic changes.
Furthermore, by comparing functional responses be-
tweenmacrophage subtypes, we propose a regulato-
ry, anti-inflammatory role of heat shock proteins of the
HSP70 family in response to long- and short-term
metabolic challenges. Our data provide a resource
for assessing the impact of nutrition andover-nutrition
on thespectrumofmacrophagesacross tissueswitha
potential for identification of systemic responses.
INTRODUCTION
Increasing evidence shows that metabolic stress such as over-
nutrition activates the immune system. Analogous to the action
against pathogens, immune cells aim to restore homeostasis
as a response to nutrient overdose (DiSpirito and Mathis,
2015). Simultaneously, over-nutrition alters the cellular meta-
bolic repertoire. Activation and differentiation of immune cells
are associated with various metabolic switches. Therefore,
altered metabolism may also adversely affect immune cell func-
tionality (O’Neill et al., 2016).Cell Re
This is an open access article under the CC BY-NGluco- and lipotoxicity driven by over-nutrition induce oxidative
stress, inflammasome activation, and cytokine production by
macrophages (DiSpirito and Mathis, 2015). Macrophages accu-
mulate in largenumbers inmanydifferent tissuesofobesehumans
andmice (Ehseset al., 2007;Libby, 2012;Weisberget al., 2003;Xu
et al., 2003). In obese adipose tissue (Lumeng et al., 2007), these
macrophages typically display an M1 phenotype and produce in-
flammatory cytokines suchas TNF-a, IL-6, IL-1b, and IL-18,which
drive insulin resistance. Furthermore, they contribute to multiple
symptoms of the metabolic syndrome, such as islet failure and
atherosclerosis (Donath, 2014; Moore et al., 2013).
Most attention has been given to adipose tissue macrophages
(ATMs) in obesity. However, tissue-specific macrophages are
found in most tissues. They support tissue homeostasis by
clearingcellular debris andareessential for tissue immunesurveil-
lancebydriving responses to infectionand resolving inflammation
(Davies andTaylor, 2015). Phenotypically and functionally, tissue-
residentmacrophages differ to a large extent. Indeed, the specific
environment of a tissue influences the transcriptional programs of
resident macrophages and shapes their functions according to
the tissue’s specific needs (Gautier et al., 2012; Gosselin et al.,
2014; Lavin et al., 2014; Okabe and Medzhitov, 2014).
With high circulating levels of nutrients, all tissues become
potentially affected by over-nutrition. The response of macro-
phages may, however, differ depending on their tissue-specific
role and the level of exposure. Alternatively, a mutual and
restricted response aiming to restore tissue homeostasis can
be expected.
Among tissue-specific macrophages, microglia have recently
attracted attention. In the mouse hypothalamus, microglia with
an inflammatory gene expression profile accumulate as early
as 3 days after initiation of high-fat diet (HFD) feeding (Baufeld
et al., 2016). Furthermore, pro-inflammatory as well as anti-in-
flammatory responses occur in hypothalamic microglia during
HFD (Baufeld et al., 2016; Gao et al., 2014; Valdearcos et al.,
2014), suggesting that the response of microglia to over-nutrition
is dynamic and temporally distinct.ports 30, 1627–1643, February 4, 2020 ª 2020 The Author(s). 1627
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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In pancreatic islets, macrophages are in close contact with b
cells and have an important regulatory role in insulin production.
Upon elevation of glucose levels, islet metabolic activity is
increased, which induces reactive oxygen species (ROS) pro-
moting the activation of NLRP3 inflammasome to enable IL-1b
production (Maedler et al., 2002; Zhou et al., 2010). In addition,
lipopolysaccharides (LPS) and free fatty acids activate TLR2
and TLR4, inducing NF-kB translocation and islet inflammation
(Bo¨ni-Schnetzler et al., 2009; Pal et al., 2012). All these compo-
nents induce low levels of islet-derived IL-1b, which in turn pro-
motes IL-1-dependent cyto- and chemokines, including IL-6, IL-
8, TNF-a, and MCP1. Furthermore, macrophages increase in
number and activity (Butcher et al., 2014; Ehses et al.,2007; Ri-
chardson et al., 2009) and adopt a pro-inflammatory phenotype
contributing to islet dysfunction and development of type 2 dia-
betes (Bo¨ni-Schnetzler and Meier, 2019).
Interestingly, food intake alone triggers a pro-inflammatory
response in myeloid cells, leading to an increase of circulating
IL-1b, which enhances insulin secretion (Dror et al., 2017). There-
fore, there is a physiological role of myeloid cell-derived IL-1b
that contrasts its deleterious role in driving insulin resistance
and b cell failure in type 2 diabetes. Altogether this shows that
macrophages are receptive to both short- and long-term nutri-
tional signals and that different or even opposing effects can
be expected (Baufeld et al., 2016; Dror et al., 2017).
To compare the effects of a selected regimen of nutritional
conditions on immune cells, we sorted uniform macrophage
populations for RNA sequencing (RNA-seq) analyses from
different murine tissues. We provide a resource of transcrip-
tomes from six tissue-resident macrophage populations and
monocytes in response to feeding, as well as three tissue-resi-
dent macrophage populations after 8 weeks of HFD and a dia-
betic condition. We investigate how distinct or similar themacro-
phage response is across different tissues and how acute versus
chronic nutritional stress affects their function.We identify a spe-
cific response of ATMs and the IL-1 pathway to food intake and
propose an anti-inflammatory role of heat shock proteins (HSPs)
across tissue-resident macrophages.
RESULTS
Distinctive Responses to Feeding across Tissue-
Resident Macrophages
We first aimed to assess the transcriptional response to food
intake across tissue-resident macrophages. Mice were fasted
(FA) for 12 h (overnight) and then refed (RE) for 2 h with regular
chow diet (Figure 1A). Tissue-resident macrophages from theFigure 1. Feeding Affects the Transcriptomes of Tissue-Resident Mac
(A) Design of fasting and refeeding experiment.
(B) Numbers of differentially expressed (DE) genes between refed (RE) and fas
numbers of overlapping DE genes between macrophage subtypes (green) (p < 0
(C) Principal-component analysis (PCA) of top 500 variable genes across all FA a
(D) PCA of top 500 variable genes across FA samples in our study and samples
(E) Network of top significantly (padj < 0.05) over-represented GO terms among
phages. Color indicates macrophage subtype, node size indicates number of D
contributing to the term. Representative terms are listed below each macrophag
See also Figures S1 and S2 and Tables S1 and S2.adipose tissue (ATM), brain (microglia), colon, pancreatic islets,
liver (Kupffer cells), and peritoneum and blood monocytes
were collected using specific surface markers (Figure S1). Four
hundred cells per cell type were isolated and used for RNA-
seq. To account for scarcity of these cell types, we used RNA
extraction, library preparation, and RNA-seq methods adapted
from single-cell protocols (see STARMethods). Six to ten biolog-
ical replicates were analyzed per cell type. We detected 8,000 to
12,000 expressed genes per macrophage subtype (Figure S2A).
Differential expression analysis was performed by comparing
macrophages/monocytes from RE and FA mice in each tissue.
Numbers of differentially expressed (DE) genes (adjusted p value
[padj] < 0.05) varied among subtypes, with most changes in peri-
toneal macrophages (481 DE genes) (Figure 1B; Table S1), while
monocytes were the least affected (20 DE genes). This did not
depend on the significance threshold or analysis method used
(Figures S2B and S2C). Because we aimed to distinguish com-
mon and divergent responses of macrophages in different tis-
sues, we compared lists of DE genes. There was little overlap
(0%–15% of common genes in all pairwise comparisons) be-
tween macrophage subtypes (Figure 1B) independent of the sig-
nificance threshold and analysis method used (Figures S2B and
S2C). This prompted us to assess the overall differences be-
tween gene expression in tissue-resident macrophages. Prin-
cipal-component analysis (PCA) revealed more pronounced dif-
ferences between macrophage subtypes than between the FA
and RE conditions (Figure 1C). Diversity of transcriptomes of tis-
sue-resident macrophages has previously also been reported
(Gautier et al., 2012; Gosselin et al., 2014; Lavin et al., 2014;
Okabe and Medzhitov, 2014). Therefore, we compared five
macrophage subtypes analyzed by Lavin et al. (2014) with data
from our study (FA samples). Macrophages from the same tissue
from two studies were more similar than from different tissues in
the same study (Figure 1D). Furthermore, hallmark tissue macro-
phage genes described by Lavin et al. (2014) had concordant
expression profiles in our data (Figure S3A). These results
confirm the high quality of our dataset, despite the small
numbers of cells used and the distinct expression patterns of
different tissue-resident macrophages found. In line with these
observations, the response to feeding differs between macro-
phage populations and is lower in magnitude than the differ-
ences between the populations themselves.
ATMs Upregulate IL-1 Signaling upon Feeding
Next, we evaluated the response of macrophage subtypes at the
functional level and performed Gene Ontology (GO) term anal-
ysis for up- and downregulated genes in the RE condition. Usingrophages
ted (FA) samples in each tissue-resident macrophage population (violet) and
.05). Color intensity of the background follows the number of DE genes.
nd RE samples of all tissue-resident macrophages.
from Lavin et al. (2014) in matching tissue-resident macrophages.
DE upregulated genes in RE versus FA comparison in tissue-resident macro-
E genes contributing to the term, and edges indicate overlapping DE genes
e name.
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Cytoscape and Enrichment Map software (Merico et al., 2010),
we visualized the overlap of over-represented GO terms for
five macrophage subtypes that showed significant terms (Fig-
ure 1E; Table S2). For upregulated genes in FA-RE, distinct
sets of terms were over-represented for each subtype, with
some overlapping terms in Kupffer cells, microglia, and perito-
neal macrophages. ATMs showedmultiple GO terms associated
with inflammation, while no such GO terms were over-repre-
sented in any other subtype.
We confirmed this observation by analyzing genes involved in
inflammation independent of the GO term gene sets (Figure 2A;
Table S3). Clustering of fold changes (FCs) (RE versus FA) of
these genes across macrophage subtypes revealed distinct up-
regulation of a pro-inflammatory gene cluster in ATMs that can
be attributed to a local, low-grade inflammatory response in
the adipose tissue. Differentially upregulated genes included
the macrophage activation marker Egr2 (Veremeyko et al.,
2018), chemokines (Cxcl1, Ccl2, Ccl7, and Ccl24), and the cyto-
kine Il1b. Importantly, IL-1b needs to be activated by the inflam-
masome and NLRP3, a crucial inflammasome component, was
also present in this cluster. Of note, the absolute Il1b and Nlrp3
expression levels were much higher in islet and colonic macro-
phages compared with other macrophages (Figure S3B), and
expression of Il1b and Nlrp3 did not increase upon feeding, indi-
cating that these macrophages are in an activated state even
without any stimulus (Ferris et al., 2017). In response to feeding,
Nlrp3 expression levels in ATMs reached the expression level in
colonic macrophages (Figure S3B), pointing to a robust
response. We validated the inflammatory response in ATMs us-
ing qPCR in two additional mouse cohorts. Both showed
increased Il1b, Cxcl1, Ccl3, and Tlr2 gene expression in
response to feeding (Figure S4).
To assess which signaling pathways drive the activation of the
IL-1 pathway, we performed pathway over-representation anal-
ysis of up- and downregulated genes in RE versus FA samples in
ATMs using the KEGG (Kyoto Encyclopedia of Genes and Ge-
nomes; https://www.kegg.jp) and MSigDB (Molecular Signa-
tures Database) canonical pathway databases (Subramanian
et al., 2005; Figure 2B). The PI3K-AKT was the top upregulated
pathway, along with receptor and effector genes such as Tlr2,
Itga9, and Mcl1. The expression of genes of the AKT signaling
cascade was not changed. However, this does not preclude
pathway activation, as signaling events in this pathway may be
mediated by phosphorylation. The JNK pathway is also impli-
cated in Il1b activation. Interestingly, this pathway was sup-
pressed in ATMs with the gene encoding for JNK (Jun) being
downregulated in RE samples.
To further elucidate the transcriptional regulation of the pro-in-
flammatory response in ATMs upon feeding, we performed tran-
scription factor (TF) binding motive enrichment analysis (Figures
2C and 2D). The consensus bindingmotive for RELA, a canonical
member of the NF-kB family, was most significantly over-repre-
sented among upregulated genes in RE condition. Indeed, the
canonical NF-kB pathway is responsible for transcriptional in-
duction of pro-inflammatory genes including Nrlp3 and Il1b
upon stimulation (Liu et al., 2017). Furthermore, in the cluster
of pro-inflammatory genes selectively activated in ATMs upon
feeding (Figure 2A), we found two upregulated modulators of1630 Cell Reports 30, 1627–1643, February 4, 2020NF-kB activity, Nfkbid and Nfkbiz, and this was confirmed using
qPCR (Figure S4). Collectively, these analyses suggest that AKT
and NF-kB signaling may drive the IL-1 inflammatory activation
in ATMs upon feeding.
Common and Differential Regulation of HSPs upon
Feeding
GO term analysis for genes upregulated upon feeding revealed
overlapping terms for Kupffer cells, microglia, and peritoneal
macrophages, associated with endoplasmic reticulum (ER)
stress and unfolded protein response (Figure 1E). HSP genes
were the main DE genes contributing to these GO terms.
We further explored the differences in HSP expression and
functionally associated genes (TFs, co-chaperones) across all
macrophages (Figure 3A). Multiple genes from the HSP70
(Hspa1a,Hspa1b,Hspa5,Hspa8, andHsph1), HSP90 (Hsp90ab1
andHsp90b1), and HSP40 (Dnaja1 andDnajb2) families were up-
regulated upon feeding in Kupffer cells, microglia, and peritoneal
macrophages but not in islet, intestine, and ATMs and mono-
cytes. Importantly, twogenes encoding inducibleHSP70proteins
(Hspa1a and Hspa1b) were significantly downregulated in RE
versus FA samples in ATMs. Anti-inflammatory effects of the
ER stress pathways and HSP70 proteins are known (Chung
et al., 2008; Di Naso et al., 2015; Oh et al., 2012), and we hypoth-
esize that ATMs downregulate HSP70 genes to activate physio-
logical responses to feeding as described above. In peritoneal
macrophages, we detected the largest number of upregulated
HSP genes and the induction of TFs responsible for their expres-
sion: Hsf1 and Xbp1 (Figure 3A). Furthermore, TF-binding motive
analysis in peritoneal macrophages (Figures 3B and 3C) revealed
that the HSF1 motive is the top over-represented one among up-
regulated genes, suggesting that this TF might drive part of the
changes observed upon feeding. HSF1 has been reported to
inhibit Il1b expression by binding to the Il1b activating TF CEBPB
(Xie et al., 2002). Accordingly, we have not observed any inflam-
matory response in peritoneal macrophages, while in ATMs that
upregulate Il1b, HSF1 was the top predicted TF binding the
downregulated genes (Figure 2D).
To validate the anti-inflammatory effect of HSP70 proteins, we
activated peritoneal macrophages in vitro with LPS and adeno-
sine triphosphate (ATP) to stimulate Il1b expression and IL-1b
secretion (Figure 3D). To analyze the role of HSP70 proteins,
we pre-treated the cells with a heat shock in the absence or in
the presence of the HSPA1A agonist BGP-15 (O-[3-piperidino-
2-hydroxy-1-propyl]-nicotinic amidoxime). The combination of
these treatments indeed reduced IL-1b secretion (Figure 3D),
and this was not due to reduced cellular viability (Figure S5).
These data further support the anti-inflammatory effect of
HSP70 proteins in macrophages.
Common Response to Food Intake across Macrophages
We observed little overlap between DE genes in different macro-
phage subtypes upon feeding (Figure 1A). We hypothesized that
there may be genes with small changes that do not pass the sig-
nificance threshold in all individual comparisons. To further inves-
tigate this potential common but mild response to food intake, we
pooled all RE versus FA samples from all macrophage subtypes
and treated them as biological replicates in the DE analysis
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Figure 2. Adipose Tissue Macrophages Activate the IL-1 Pathway in Response to Feeding
(A) Heatmap of log2 fold changes (RE versus FA) of 170 selected inflammatory genes (provided in Table S3). The cluster of genes selectively activated in ATMs is
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See also Figures S3 and S4 and Table S3.
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Statistical analysis was performed using one-way ANOVA and the Holm-Sidak multiple-comparisons posttest. **p < 0.01, ***p < 0.001, and ****p < 0.0001. See
also Figure S5.(Figure 4A; Table S4). Among top upregulated genes, we found
Slc2a1 encoding for GLUT1, which is the main transporter in
macrophage glucose metabolism and involved in the induction
of inflammation (Freemerman et al., 2014). The individual log2
FC in macrophage subtypes varied between 0.03 and 1.46 and
washighest inperitonealmacrophages (Figure4B). This is consis-
tent with IL-1b-dependent upregulation of GLUT1 and glucose
uptake in macrophages in vitro as well as systemic upregulation
of glucose uptake in response to feeding (Dror et al., 2017).
Interestingly, Cpt1a, a gene encoding a long chain fatty acid
transporter acting at the rate-limiting step of fatty acid oxidation1632 Cell Reports 30, 1627–1643, February 4, 2020(FAO) was among the top downregulated genes in pooled RE
versus FA samples (Figure 4A), with the largest downregulation
in islet macrophages (Figure 4B). Differential up- and downregu-
lation of Slc2a1 and Cpt1a point to a change from fatty acid to
glucose utilization. This metabolic switch has been described
in multiple immune cell types upon activation (O’Neill et al.,
2016), including macrophages upon HFD feeding (Freemerman
et al., 2014; Malandrino et al., 2015).
We further performed pathway analysis for up- and downregu-
lated genes from pooled RE versus FA comparison (Figure 4C;
Table S5). Top upregulated pathways included ‘‘phagosome’’
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Figure 4. Common Metabolic Response to Feeding across Tissue-Resident Macrophages
(A) Volcano plot of DE analysis of all RE versus all FA samples from tissue-resident macrophages. DE geneswith padj < 0.05 are marked in blue (downregulated) or
red (upregulated). Gene names are displayed for top DE genes.
(legend continued on next page)
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and ‘‘antigen processing and presentation,’’ indicating activation
of canonical macrophage functions. Top downregulated path-
ways comprised ‘‘glycerolipid metabolism’’ and ‘‘fatty acid
oxidation,’’ with contributing downregulated genes Cpt1a,
Aldh9a1, Plin2, and Pnpla2 (Figures 4B and 4C). This further sup-
ports the downregulation of fatty acid utilization and a systemic
metabolic response to feeding across all tissue macrophages.
Ribosomal small- and large-subunit genes were also downregu-
lated across macrophage subtypes (Figures 4B and 4C), a previ-
ously described hallmark of macrophage activation (Varesio
et al., 1992).
Altogether, this reveals that although a major part of the
responses to feeding is divergent between the different tissue-
resident macrophages, there remain common hallmarks of acti-
vation across all tissues.
Distinct Responses of Tissue-Resident Macrophages to
HFD and Diabetic Conditions
Next we assessed the phenotype of selected tissue-resident
macrophages to long-term metabolic challenge. Mice were fed
an HFD for 4 weeks, then treated with a single low dose of strep-
tozotocin (HFD-STZ) (130mg/kg) or control to reduce b cell mass
and to induce hyperglycemia (Figures S6A–S6C) and fed a HFD
for another 4 weeks (Figure 5A). A third group consisted of
initially weight-matched, chow food-fed littermates (ND). Islet
macrophages, peritoneal macrophages, and microglia were iso-
lated using fluorescence-activated cell sorting (FACS) (Figure S1)
and subjected to RNA-seq.
Similar to the FA-RE experiment, the effect of HFD and HFD-
STZ treatment was less prominent than the differences between
macrophage subtypes (Figure 5B). However, PCA for samples
from either islet or peritoneal macrophages, but not microglia,
segregated the samples according to their treatment groups,
ND, HFD, and HFD-STZ (Figure 5B).
HFD leads to elevated circulating lipid levels with toxic effects
for tissues (DiSpirito and Mathis, 2015). The additional treatment
of HFD-fed mice with STZ results in reduced plasma insulin and
therefore diabetic blood glucose levels. Both conditions may
trigger common and divergent responses in tissue-resident
macrophages. Therefore, we first performed DE analysis in
each macrophage subtype, comparing HFD and HFD-STZ sam-
ples with ND samples, followed by clustering of DE genes on the
basis of their expression pattern across all conditions (Figures
5C–5F; Table S6), using the weighted correlation network anal-
ysis (WGCNA) (Zhang and Horvath, 2005). Furthermore, we
compared themodules between themacrophage subtypes (Fig-
ure 5G) and annotated themwith GO terms (Figure 5H; Table S7).
In islet macrophages, 1,348 DE genes were clustered into six
modules (Figure 5D), with the largest numbers of genes in mod-
ules I-1 and I-5. In both modules, genes responded to both HFD
and HFD-STZ conditions (up inmodule I-1 and down inmodule I-
5), but themagnitude of the response was higher in the HFD-STZ(B) Heatmap of log2 fold changes from individual RE versus FA comparisons in
processes and of ribosomal subunits.
(C) Top significantly (padj < 0.05) over-represented pathways among upregulated
tissue-resident macrophages. DE genes contributing to the pathway are listed in
See also Tables S4 and S5.
1634 Cell Reports 30, 1627–1643, February 4, 2020condition. This indicates that the effect of lipids on the cells was
enhanced by elevated blood glucose. Of note, module I-1 con-
tained Slc2a1 encoding glucose transporter GLUT1 and Hk2, a
rate-limiting enzyme of glycolysis, again pointing to a metabolic
switch to glucose utilization as described above. Arginase 2 en-
coded byArg2was found in this module as well, while its isoform
Arg1was downregulated inmodule I-5.Arg1 expression is a hall-
mark of the anti-inflammatory M2 phenotype (Rath et al., 2014).
In module I-1, we found Il1rn, which is an IL-1 receptor antago-
nist, indicating upregulation of anti-inflammatory mechanisms.
Furthermore, module l-5 included several downregulated pro-
inflammatory chemo- and cytokines. However, classical inter-
feron-inducible genes such as Ifi44, Oas1g, and Cd38 were
upregulated. In module I-1, we further found upregulated Igf1,
consistent with a recent report on islet macrophages secreting
IGF1 that promotes islet regeneration (Nackiewicz et al., 2020).
All DE genes with module annotation are listed in Table S6.
In peritoneal macrophages, 1,562 DE genes were clustered
into seven modules (Figure 5E). The majority of upregulated
genes were grouped into module P-4. They did not change
upon HFD but were upregulated in the HFD-STZ condition.
Cpt1a, which catalyzes the primary regulatory step of FAO, as
well as the fatty acid transporter Slc27a1, were found in this clus-
ter, together with the master transcriptional regulator of lipid
metabolism Pparg. PPARg coactivators Ppaprgc1a and
Ppargc1b, found in module P-2, were also upregulated, in both
HFD and HFD-STZ conditions. PPARg activation and upregula-
tion of FAO are hallmarks of metabolic reprogramming associ-
ated with anti-inflammatory responses (O’Neill et al., 2016).
The majority of downregulated genes was part of modules P-5
and P-6, downregulated either in both HFD and HFD-STZ (P-5)
or only in HFD-STZ (P-6). Consistent with a metabolic switch,
we found Hk1, a rate-limiting enzyme of glycolysis, downregu-
lated in module P-6. Altogether, these changes point to an
anti-inflammatory metabolic phenotype of peritoneal macro-
phages in the HFD-STZ condition (see Table S6 for all DE genes
with module annotation).
We systematically compared the responses in islet and perito-
neal macrophages by checking their module overlaps (Fig-
ure 5G). We generally observed small numbers of overlapping
genes. The largest and most significant overlap (24 genes) was
between modules I-1 (genes up in HFD and HFD-STZ) in islet
and P-4 in peritoneal macrophages (genes up in HFD-STZ).
These included, among others, interferon-inducible genes
described above andMs4a4a andMs4a6d. MS4A4A is a marker
of alternatively activated M2 macrophages (Sanyal et al., 2017),
and MS4A6D suppresses Il1b and Nlrp3 expression in macro-
phages (Huang et al., 2019). Indeed, in both islet and peritoneal
macrophages, we did not observe upregulation of Il1b, although
it is an established hallmark of inflammation in ATMs in HFD-fed
mice and obese humans (Bing, 2015; DiSpirito and Mathis,
2015).each tissue macrophage subtype for selected genes involved in metabolic
(pink) and downregulated (blue) DE genes in all RE versus all FA samples from
each bar, and corresponding FDR values are listed on the right.
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In microglia with only 77 DE genes, five modules were identi-
fied (Figure 5F). Module M-1 contained genes upregulated in
both HFD and HFD-STZ conditions, with higher response in
the latter, including multiple HSP genes: HSP40 family members
Dnaja1 and Dnajb1, HSP70 members Hspa1a and Hspa8, co-
chaperones Bag3 and Hsph1, and HSP90 family member
Hsp90aa1. Interestingly, Hspa1a and Hspa8 were not only upre-
gulated in microglia upon long-term metabolic challenge but
were also induced upon short-term feeding (Figure 3A). In hypo-
thalamic microglia, an inflammatory response was observed
after 3 days of HFD, which was attenuated after 8 weeks, with
anti-inflammatory genes such as Pparg activated at that later
time point (Baufeld et al., 2016). In our study with brain microglia
analyzed after 8 weeks of HFD, we did not find any pro-inflam-
matory DE genes (Figure 5F; Table S6). Functional analysis re-
vealed no inflammation-associated processes (Figure 5H; Table
S7). These data further support an anti-inflammatory role of
HSP70 gene upregulation.
As there were far fewer DE genes in microglia than in islet and
peritoneal macrophages, we did not compare their modules. Of
note, hormone or hormone-processing gene transcripts, which
are abundantly expressed in endocrine b, a, and d cells (Ins2,
Iapp,Gcg, Sst, Pcsk1, and Pcsk2), were detected in islet macro-
phages but not in peritoneal macrophages and microglia (Fig-
ure S6D). This may result from engulfment of secretory vesicles
(Ying et al., 2019) or phagocytosis of endocrine cells.
M1 Signature in Islet Macrophages and Fatty Acid
Activation Signature in Peritoneal Macrophages
Activated macrophages are typically categorized into M1 IFNg
activated (pro-inflammatory) and M2 IL-4 activated (anti-inflam-
matory). To evaluate to what extend macrophage responses to
HFD and STZ can be described by this simple categorization,
we analyzed M1 and M2 signature gene (Jablonski et al., 2015)
expression in our data (Figures 6A–6C). In this analysis, proper
clustering of samples into experimental groups on the basis of
signature genes indicated that these genes were DE between
the analyzed conditions. For islet macrophages, hierarchical
clustering of samples on the basis of 77 M1 signature genes re-
sulted in perfect separation of ND and HFD and of ND and HFD-
STZ experimental groups (Figure 6A). Furthermore, three genes
of the M1 signature were significantly upregulated in HFD and
seven in the HFD-STZ condition. Hierarchical clustering of sam-
ples on the basis of 45 M2 signature genes did not separate
experimental groups for ND and HFD samples, whereas NDFigure 5. HFD and STZ Trigger Differential Responses in Islet and Per
(A) Design of HFD and HFD-STZ experiment.
(B) Principal-component analysis (PCA) of top 500 variable genes across ND, HFD
or in specific tissues: islet macrophages (orange, top right), peritoneal macropha
(C) Scheme of DE and clustering analysis for ND, HFD, and HFD-STZ samples.
(D–F) Modules of DE genes showing similar expression profile across ND, HFD, a
and (F) microglia. Mean expression level of three to five biological replicates is dis
module and genes of special interest are indicated.
(G) Numbers of overlapping genes betweenmodules from (D) (islet macrophages)
overlap (Fisher’s exact test).
(H) Top over-represented GO terms for modules from (D)–(F). For a GO term that
marked in blue. Modules that had no significant terms are not listed.
See also Figure S6 and Tables S6 and S7.
1636 Cell Reports 30, 1627–1643, February 4, 2020and HFD-STZ samples were perfectly separated. However,
contributing genes were downregulated in HFD-STZ compared
with ND samples, five of them significantly. Therefore, islet mac-
rophages acquire an M1-like and suppress an M2 phenotype in
response to HFD and STZ.
For peritoneal macrophages, hierarchical clustering of M1
signature genes nearly perfectly separated the groups (Fig-
ure 6B). However, genes contributing to the signature were
both down- and upregulated. Clustering of samples on the basis
of M2 signature perfectly separated the samples for ND and
HFD-STZ groups, but again, both up- and downregulated genes
contributed to it. In conclusion, peritoneal macrophages dis-
played a mix of M1-like and M2-like phenotypes, activating
and suppressing both M1 and M2 phenotype elements.
In microglia, samples could not be separated into experi-
mental groups with either M1 nor M2 signature (Figure 6C).
None of the signature genes were DE, indicating that the
response ofmicroglia to HFD and STZ is not related to a classical
type of activation.
The M1-M2 classification, although still commonly used, has
been questioned (Martinez and Gordon, 2014; Murray et al.,
2014). A larger spectrum of stimuli or in vivo rather than in vitro
setups was used to extend this classification (Kratz et al.,
2014; Xue et al., 2014). To characterize the phenotype of macro-
phages in HFD and STZ conditions, we used the spectrummodel
of macrophage activation proposed by Xue et al. (2014). They
defined signatures of human macrophages subjected to 29
different in vitro stimuli and provided a framework for signature
evaluation using gene set enrichment analysis (GSEA) (Subra-
manian et al., 2005). We used human homologs of mouse genes
to query these signatures. For islet macrophages, the highest
scoring (by enrichment score and p value) signature was the
one derived from IFNg for both HFD and HFD-STZ responses
(Figure 6E), consistent with the good match with the above-
described M1 signature of mouse macrophages. For peritoneal
macrophages, the highest scoring signatures were those of lino-
leic acid and oleic acid in HFD and oleic acid in the HFD-STZ
condition (Figure 6E). Therefore, a standard response to fatty
acids, which is shared in vitro and in vivo and is distinct fromclas-
sical M1 and M2 phenotypes, seems to exist in macrophages.
A Mixed M1/M2 Phenotype Is a Cellular Property of
Peritoneal Macrophages
On the basis of size and F4/80 and CD11b expression, peritoneal
cavity macrophages can be subdivided into two functionallyitoneal Macrophages and Microglia
, and HFD-STZ samples in all analyzed tissue-resident macrophages (top left)
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distinct subsets (Ghosn et al., 2010). To assess whether the mix
of M1- and M2-like phenotypes observed in our RNA-seq data-
set could be attributed to differences in these populations, pro-
tein levels of the M1-marker iNOS and the M2-marker CD206
were analyzed on small peritoneal macrophages (SPMs; defined
as live single CD19CD11c F4/80low CD11blow) and large peri-
toneal macrophages (LPMs; defined as live single CD19
CD11c F4/80high CD11bhigh) using flow cytometry (Figure S7).
In agreement with previous studies (Ghosn et al., 2010), most
peritoneal cavity macrophages were identified as LPMs, while
SPMs only made up about 2%–5% of cells. LPMs in ND-fed
mice were characterized by a mixedM1- andM2-like phenotype
(Figure S7G). In contrast, themajority of SPMswere polarized to-
ward an M1-like phenotype (Figure S7H). HFD did not change
the proportions of LPMs and SPMs or their polarization profile
compared with ND (Figures S7F–S7H), indicating that the mixed
M1/M2 phenotype observed in our transcriptional analysis is not
an artifact.
Short- versus Long-Term Metabolic Challenge
Macrophages protect tissues from pathogens but also maintain
homeostasis upon physiological changes. Feeding results in
temporarily elevated nutrients in the bloodstream and tissues.
Long-term over-feeding provides constantly elevated nutrients
in the circulation. This may potentially activate similar responses
across tissue-resident macrophages. To evaluate this hypothe-
sis, we compared the responses to feeding and to HFD in islet
macrophages (Figure 7A), peritoneal macrophages (Figure 7B),
and microglia (Figure 7C). We found very few overlapping genes
between these two conditions. In islet macrophages, only seven
genes were commonly DE, and just three of them changed in the
same direction. Cd36, a fatty acid translocase, was downregu-
lated in both conditions. As it is involved in NLRP3 inflamma-
some activation (Sheedy et al., 2013), its downregulation is
consistent with lack of IL-1 pathway upregulation. As described
above, the IL-1 pathway is constitutively active in islet macro-
phages, similarly to barrier macrophages (Ferris et al., 2017),
and downregulation of Cd36 may have a role in maintaining
this steady state in response to both short- and long-term meta-
bolic challenge.
In peritoneal macrophages (Figure 7B), we found 20 sharedDE
genes upregulated in HFD and feeding conditions. Interestingly,
this common response included four tubulin (Tubb6, Tuba1a,
Tubb4b, and Tubb2a), one laminin (Lmna), and one vimentin
(Vim) gene, indicating cytoskeleton re-organization that could
reflect phagocytosis, migration, and/or differentiation. Macro-
phagesmigrate from omentum to peritoneum (Okabe andMedz-Figure 6. HFD and STZ Trigger M1-like Signature in Islet Macrophages
(A–C) Heatmaps of normalized expression values of ND, HFD, and HFD-STZ sam
of M1 andM2 signature genes (Jablonski et al., 2015). Genes are sorted on the ba
are highlighted and listed (red, upregulated genes; blue, downregulated genes). C
to either HFD or HFD-STZ.
(D and E) Volcano plot of GSEA of genes responding to 29 stimuli reported by
macrophages fromHFD versus ND (left panel) and HFD-STZ versus ND (right pane
genes (p < 0.05) are indicated in red and blue, respectively. Significant signatures
and stimuli correlating with a given signature are listed.
See also Figure S7.
1638 Cell Reports 30, 1627–1643, February 4, 2020hitov, 2014), potentially also upon feeding, as macrophage
numbers increased in peritoneum and decreased in omentum
(Dror et al., 2017).
DISCUSSION
There is increasing evidence that metabolic syndromes such as
obesity and diabetes affect the whole organism. The majority of
research has focused on the adipose tissue as an obviously
affected organ, and ATMs have been established as macro-
phages driving obesity-associated low-grade inflammation (Lu-
meng et al., 2007; Weisberg et al., 2003). Our study provides a
resource to investigate the effect of over-nutrition and the physio-
logical response to feeding across macrophages in additional
tissues.
A large proportion of research in macrophages has been per-
formed in vitro, providing a simplified view of macrophage re-
sponses, as the situation in vivo is more complex (Martinez and
Gordon, 2014). However, populations of tissue-resident macro-
phages such as isletmacrophages are sparse, and only advance-
ments of technologies such as RNA-seq have enabled their anal-
ysis. In our study, we successfully isolated and analyzed
transcriptomes of adipose tissue, colonic, islet, and peritoneal
macrophages as well as Kupffer cells, microglia, and monocytes
from purified populations as small as 400 cells. Still, there are
several limitations of in vivo analyses. Macrophage populations
in different tissues may be more heterogeneous than previously
anticipated. For example, two macrophage subtypes were re-
ported in islets: intra- and peri-islet macrophages (Ying et al.,
2019). However, further identification of markers for specific sub-
populations is needed. Another challenge of in vivo analysis is the
necessity of different procedures to isolate macrophages in
different tissues, and these may have an effect on the activation
status of the cells. To overcome this issue, our comparisons be-
tween macrophages from different tissues are based on relative
responses between treatment and control within one tissue,
which cancels out isolation effects.
Our analysis of the spectrum of tissue-resident macrophages
revealed that there is little overlap between the responses to
short-term (Figures 1B and 1E) and long-term metabolic chal-
lenge (Figure 5G). This is consistent with highly variable tran-
scriptomes of tissue-resident macrophages in the steady state
(Gautier et al., 2012; Gosselin et al., 2014; Lavin et al., 2014;
Okabe and Medzhitov, 2014). On the basis of our data, the
response of each macrophage subtype could be further
explored. Here, we focused on the low-grade inflammation of
ATMs that we observed upon feeding (Figure 2). Our analysesand Fatty Acid Activation Signature in Peritoneal Macrophages
ples from (A) islet macrophages, (B) peritoneal macrophages, and (C) microglia
sis of the adjusted p value in the current experiment, and genes with padj < 0.05
lustering of biological replicates indicates genes that are changing in response
Xue et al. (2014) for DE genes from (D) islet macrophages and (E) peritoneal
l) comparisons. Signatures significantly enriched among up- and downregulate
are annotated with a number corresponding to numbering by Xue et al. (2014)
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and (C) microglia.with RNA-seq and qPCR revealed an early first response to
feeding characterized by the activation of the pro-inflammatory
IL-1 pathway (Figure 2A; Figure S4), potentially driven by AKT
and NF-kB signaling (Figures 2B and 2C). In line with this obser-
vation, physiological activation of pro-inflammatory pathways is
required for mouse adipose tissue expansion and remodeling
(Wernstedt Asterholm et al., 2014). Furthermore, human pre-ad-
ipocytes and adipocytes express the IL-1 receptor 1 (Il1r1), and
IL-1b regulates metabolic genes (Cae¨r et al., 2017). Together,
these findings point to a role of ATMs and the IL-1 system in
the regulation of adipose tissue biology upon feeding. Further-
more, an increase of IL-1b in the circulation has been observed
in mice 2 h after feeding. This led to enhanced insulin secretion
and glucose uptake into peritoneal macrophages via GLUT1
transporter (Dror et al., 2017). Consistently, we observed sys-
temic upregulation of Slc2a1 across tissue-resident macro-Cell Repophages (Figures 4A and 4B) and propose
that ATMs might be a major source of the
increased IL-1b upon feeding.
As described before (Calderon et al.,
2015; Ferris et al., 2017), we observed
much higher absolute levels of Il1b and
Nlrp3 in colonic and islet macrophages,
pointing to constitutively active IL-1
signaling (Figure S3B). This may explain
why the expression of these genes is not
increased upon feeding or the HFD or
HFD-STZ condition. Nevertheless, islet
macrophages of HFD- and HFD-STZ-
treated mice can be classified as M1 (Fig-
ure 6A) and IFNg activated (Figure 6D).
This suggests that the steady-statepro-in-
flammatory phenotype is enhanced under
these conditions, consistent with islet
inflammation in response to elevated
glucose and lipids (Bo¨ni-Schnetzler et al.,
2008, 2009; Ying et al., 2019).
In ATMs, a distinct phenotype associ-
ated with obesity and diabetes, termed
metabolic activation, has been described
(Kratz et al., 2014). It contains elements of
both classical M1 (pro-inflammatory) and
alternative M2 (anti-inflammatory) activa-
tion hallmarks. Here, we described that a
mix of M1 andM2 signatures can be simi-
larly detected in peritoneal macrophages
(Figure 6B). Furthermore, they were clas-sified as lipid activated (Figure 6E) and upregulated Pparg and
lipid metabolism genes (Figure 5E), similarly as described for
metabolic activation in ATMs (Kratz et al., 2014).
Across analyzed macrophages subtypes and treatments, we
observed upregulation of HSP genes, mainly from the HSP70/
HSP90 chaperone system (HDSP40, HSP70, and HSP90 fam-
ilies) (Figures 3A and 5D–5F), which is further supported by up-
regulation of HSP driving TFs (Hsf1 and Xbp1) and TF enrich-
ment motive analysis in peritoneal macrophages (Figure 3B).
Downregulation of the two HSP70 family members Hspa1a
and Hspa1b is observed only in ATMs upon feeding (Figure 3A).
This was the only condition for which we observed upregulation
of the IL-1 pathway (Figure 2A). The anti-correlation between
HSP expression and IL-1 pathway activity is also supported
by HSF1’s function in repressing Il1b (Xie et al., 2002). Hence,
we propose an anti-inflammatory role of HSP70 members inrts 30, 1627–1643, February 4, 2020 1639
tissue-resident macrophages upon metabolic challenge. The
main functions of the HSP70/HSP90 chaperone system are
the assistance of proper protein folding in the ER and degrada-
tion of misfolded or aggregated proteins (Schopf et al., 2017).
HSPs are also involved in immunity, inflammation, and neuro-
degeneration (Lackie et al., 2017; Lee and Repasky, 2012).
Anti-inflammatory properties of the HSP70 family and specif-
ically of HSPA1A have been described, and the HSPA1A
agonist molecule BGP-15 had positive effects in trials against
diabetes and adverse effects of obesity (Chung et al., 2008;
Henstridge et al., 2014; Litera´ti-Nagy et al., 2012). We used
this molecule in a validation experiment and confirmed the
anti-inflammatory effect of this HSPA1A agonist on macro-
phages, as measured by decrease of IL-1b secretion (Fig-
ure 3D). Mechanistically, downregulation of Il1b expression
could be further explained by inhibitory effects of HSP70 on
the NF-kB pathway. HSP70 was shown to destabilize TAK1,
an activator of NF-kB pathway, through competition for
HSP90 binding (Cao et al., 2012) and to destabilize the TAK1
interactor TRAF6 (Chen et al., 2006).
In contrast to previously reported anti- or pro-inflammatory
responses (Baufeld et al., 2016; Gao et al., 2014; Valdearcos
et al., 2014), we saw few changes in HFD and HFD-STZ con-
ditions in microglia (Figure 5F). As the response changes in
the course of HFD, we may have missed it at the 8 week
time point. Furthermore, the magnitude of the reported
changes in inflammatory gene expression does not exceed
1.5-fold. In fact, all previous studies focused on hypothalamic
microglia (Baufeld et al., 2016; Gao et al., 2014; Valdearcos
et al., 2014). Therefore, the HFD-induced effect may have
been masked in our whole-brain microglia analysis. Impor-
tantly, in the fasting-refeeding experiment, we observed
similar numbers of DE genes in microglia (Figure 1B) as in
other macrophages subtypes indicating that we did not
face a technical issue with microglia cells.
In summary, we provide a resource that will help dissect the
role of tissue-resident macrophages in response to nutrition in
both physiological and chronically overdosed conditions. We
pinpoint ATMs and the IL-1 pathway as early sensors of nutri-
tional status, an observation that awaits further evaluation and
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high-fat diet (58% fat, 26% carbohydrates
and 16% protein)
Research Diets Cat# D12331
high-fat diet ssniff Spezialita¨ten, Soest, Germany Cat# EF D12492 (I) mod. 60 kJ% fat [Lard]LEAD CONTACT AND MATERIALS AVAILABILITY
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Sophia
Julia Wiedemann (sophia.j.wiedemann@gmail.com). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Experimental mice were obtained from our in-house breeding (littermate C57BL/6N). All mice were male, unless otherwise specified.
The age of themice used for individual experiments is specified below. Littermates of the same sexwere randomly assigned to exper-
imental groups unless otherwise specified. All animal experiments were approved by the Swiss Authorities and conducted according
to local Institutional Guidelines and the Swiss Veterinary Law.Wherever possible, each cage includedmice receiving all treatments in
order to avoid cage-dependent effects.
METHOD DETAILS
Animal husbandry
All animals were housed in a temperature-controlled room with a 12 h light–12 h dark cycle and free access to food and water unless
otherwise indicated. Fasting and refeeding experiments were performed at 8 weeks of age and as previously described in Dror et al.
(2017) usingweight-matched littermatemalemice: ‘‘micewere fasted overnight for 12 hoursmeaning theywere provided free access
to water but not to food. Refed mice were then allowed access to the food they were accustomed to for a period of 2h, while fasted
mice were kept fasted for an additional 2 hours. To avoid potential confounding effects due to circadian-cycle-mediated fluctuations
in circulating IL-1b concentrations, all experiments were performed at the same time of the day (between 8 a.m. and 10 a.m.).’’e3 Cell Reports 30, 1627–1643.e1–e7, February 4, 2020
For HFD-STZ experiments, initially weight-matched 9-week old littermatemalemice were either kept on normal CHOW ( =ND con-
dition) or fed a high-fat diet (D12331, Research Diets; 58% fat, 26% carbohydrates and 16% protein, = HFD condition) for 8 more
weeks total. During the fourth week of high-fat diet feeding, mice were subjected to an intraperitoneal injection of either 130 mg/
kg Streptozotocin (Sigma, dissolved in citrate buffer (pH 4.5), = HFD-STZ condition) or control solution (0.9% saline).
Primary cell isolation
Monocytes, peritoneal macrophages, Kupffer cells, adipose-tissue macrophages and colonic macrophages were isolated as
described in Dror et al. (2017).
Briefly, and taken/adapted from Dror et al.: following euthanasia in a CO2 chamber, ‘‘the mouse heart was punctured, and the
collected blood was incubated briefly with red-blood-cell lysis buffer (154 mM NH4Cl, 10 mM KHCO3 and 0.1 mM EDTA) to obtain
circulating blood leukocytes. To isolate peritoneal macrophages, the peritoneum was infused with FACS buffer (PBS with 0.5% BSA
and 5mMEDTA) and the lavage was filtered through 70-mmcell strainer (#431751, Corning). Kupffer cells were isolated from the liver
perfused with 4 ml collagenase (1.4 gr/l; collagenase type 4; Worthington) through the ductal vein followed by a 30-min incubation
step at 37C and two centrifugation steps: 50 3 g for 3 min at 4C, collection of the upper phase and 350 3 g for 5 min at 4C. In-
testinal macrophages were isolated after removal of the intestinal payer patches, cut in pieces and washed twice (20 min shaking in
PBS with 5 mM EDTA), followed by 30 min of incubation in collagenase type 4 (1.4 gr/l; Worthington) at 37C. Cells from the epidid-
ymal fat pads were isolated after shaking with collagenase type 4 (1.4 gr/l; Worthington) for 30 min at 37C. Spleens were pushed
through a 70-mm cell strainer (#431751, Corning) and red blood cells were lysed using lysis buffer (154 mM NH4CL, 10 mM
KHCO3 and 0.1 mM EDTA).’’
Islet macrophages were isolated as described in Dalmas et al., 2017. Briefly, and taken from Dalmas et al. (2017): ‘‘To isolate
mouse islets, pancreata were perfused through the common bile duct with a HBSS collagenase solution (1.4 g/L; collagenase
type 4 Worthington) and digested in the same solution in a 37C water bath for 28 min. After shaking for 15 seconds, pancreata
were washed three times with HBSS supplemented with 0.5% bovine serum albumin (BSA) and filtrated through 500 mm and
70 mm cell strainers (Corning). Islets were retained on the 70 mm cell strainer while the cell mixture passing through the 70 mm cell
strainer represented the exocrine stoma. Islets from the same condition were handpicked and pooled into a Petri dish with RPMI-
1640 (GIBCO) containing 11.1 mM glucose, 100 units/ml penicillin, 100 mg/ml streptomycin, 2 mMGlutamax, 50 mg/ml gentamycin,
10 mg/ml Fungison and 10% FCS (Invitrogen). To obtain single cells, islets were gently dispersed with a 0.0125% trypsin-EDTA
(GIBCO) solution for 2 min in a 37C water bath, washed with cold FACS buffer (PBS with 0.5% BSA and 5 mM EDTA), centrifuged
at 300 x g, 4C for 5 min and resuspended in FACS buffer.’’
Microglia were isolated from mice treated as described above following euthanasia in a CO2 chamber. Briefly, mice were initially
perfused with an ice-cold 0.9% saline solution. Whole brains were then excised from the skull and mechanically dissociated in FACS
buffer (PBSwith 0.5%BSA and 5mMEDTA) using a Dounce-homogenizer (#D9938-1SET, Merck). Cells were then passed through a
70-mm cell strainer (#431751, Corning), washed with FACS buffer (PBS with 0.5% BSA and 5 mM EDTA) and dissolved in a 37%
isotonic Percoll solution (#17-0891-01, GE Healthcare). 37% Percoll was then layered on top of a 70% isotonic Percoll solution
and centrifuged for 30 minutes at 750 3 g using minimal brake. The microglia-containing interphase was subsequently collected
and filtered through a 70-mm cell strainer, washed and again resuspended in FACS buffer (PBS with 0.5% BSA and 5 mM EDTA).
Cell culture
For the culture of peritoneal macrophages, cells were allowed to adhere for at least 3 h in 60 3 15 mm circular cell culture dishes
(#82.1194.500, Sarstedt). Then non-adherent cells were washed away vigorously, and naive macrophages were used for cyto-
kine-release assays. Briefly, naive peritoneal macrophages were seeded into standard 96-well plates (#92097, TPP) at a density
of 50’000 cells/well following trypsinization (#154000-054, GIBCO). Cells were pre-incubated either at 37C (control condition) or
41C (heat condition) ± BPG-15 (50mM, #B4813-5MG, Sigma) for 30 minutes. Following pre-incubation, cells were primed for 3h
with 100 ng/ml LPS (#tlrl-smlps, InvivoGen). Then, cytokine release was induced by a further 30 min incubation step with ATP
(5 mM; #tlr-atp, InvivoGen). Supernatants were subsequently collected and centrifuged (at 4C, 450 3 g for 5 min) and then stored
at 80C. Remaining cells were harvested for flow cytometry and assessed for viability using the DNA-binding dye DAPI (4’,6-Dia-
midino-2-Phenylindole, Dilactate; #422801, BioLegend).
Flow cytometry
For cell sorting
Cells were incubated with an Fc blocking antibody (anti-mouse CD16/CD32 clone 93, #14-0161-85, eBioscience) for 15 minutes at
room temperature, and subsequently labeled with the following antibodies for 30min at 4C in the dark: APC anti-mouse CD45 [clone
30-F11] (#17-0451-83, eBioscience), PE anti-mouse CD11b [cloneM1/70] (#12-0112-81, eBioscience) and PECy7 anti-mouse F4/80
[clone BM8] (#25-4801-82, eBioscience). In case of monocytes, the following antibodies were used: APC anti-mouse CD115 [clone
AFS98] (#17-1152-82, eBioscience), PerCP-Cyanine5.5 anti-mouse Ly6C [clone HK1.4] (#45-5932-82, eBioscience) and APC-Cy7
anti-mouse Ly6G [clone 1A8] (#127624, BioLegend). Appropriately stained cells were then washed twice with FACS buffer (PBS
with 0.5% BSA and 5 mM EDTA). Viability staining was done using the DNA-binding dye DAPI (#422801, BioLegend). Cells were
then further enriched into tissue-resident macrophage populations by fluorescence-activated cell sorting (FACS) on a BD FACS-AriaCell Reports 30, 1627–1643.e1–e7, February 4, 2020 e4
III. Monocytes were defined as live (DAPI-) single CD115+ Ly6G- Ly6C+. Adipose tissuemacrophages, Kupffer cells, peritoneal mac-
rophages, intestinal macrophages and islet macrophages were defined as live single CD45+CD11b+ F4/80+. Microglia were defined
as live single CD11b+ CD45int. For a representative example of the gating strategy see Figure S1. With regards to cell number, for the
refeeding experiment, 400 cells of each macrophage subtype were sorted per sample. For the HFD-STZ experiment, 400 islet mac-
rophages, 5000 microglia and 100’000 peritoneal macrophages were sorted per sample.
For the analysis of LPM and SPM peritoneal macrophage subsets
Peritoneal cells, isolated as described above and in Dror et al. (2017) from 16week old, 8 weeks HFD-fed (EF D12492 (I) mod. 60 kJ%
fat [Lard]; ssniff Spezialita¨ten, Soest, Germany) or CHOW-fed littermate control mice, were incubated with an Fc blocking antibody
(anti-mouse CD16/CD32 clone 93, #14-0161-85, eBioscience) for 15 minutes at room temperature, and subsequently labeled with
the following antibodies for 30 min at 4C in the dark: PE-Cy7 anti-mouse CD11c [clone N418] (#25-0114-81, eBioscience), Super
Bright 600 anti-mouse CD19 [clone 1D3] (#63-0193-82, invitrogen), PE-Texas Red anti-mouse CD11b [clone M1/70.15]
(#RM2817, eBioscience), PerCP-Cy5.5 anti-mouse F4/80 [clone BM8] (#123127, BioLegend) (or alternatively APC-Cy7 anti-mouse
F4/80 [clone BM8] (#123118, BioLegend)) and Alexa Fluor 647 anti-mouse CD206 [clone C068C2] (#141712, BioLegend). Viability
staining was done using the Fixable Viability Dye eFluor 455UV (#65-0868-18, eBioscience) according to the manufacturer’s instruc-
tions. Appropriately stained cells were then washed once with FACS buffer (PBS with 0.5% BSA and 5 mM EDTA) and further pre-
pared for intracellular staining using the intracellular Fixation and Permeabilization Buffer Set (#88-8824, eBioscience) and protocol.
Intracellular staining was done using the following antibody: PE anti-mouse iNOS [clone CXNFT] (#12-5920-82, Invitrogen). Cells
were analyzed on a BC CytoFLEX. Small peritoneal macrophages (SPM) were defined as live single CD19- CD11c- F4/80low
CD11blow. Large peritoneal macrophages (LPM) were defined as live single CD19- CD11c- F4/80high CD11bhigh. Gating was per-
formed uniquely with reference to fluorescence minus one controls (FMOs). For a representative example of the gating strategy
see Figure S7.
RNA extraction for validation and qPCR
Total RNA was extracted using the Nucleo Spin RNA II Kit (Machery Nagel). RNA concentrations were normalized, and cDNA was
prepared with the GoScript Reverse Transcription Mix using Random Primers (#A2801 GoScript) according to the manufacturer’s
instructions. RNA expression was determined using SYBR Green assays with GoTaq qPCR Master Mix (#A600A Promega) and
the ViiA 7 Real-Time PCR System (ThermoFisher Scientific). Primers for SYBR Green-based qPCR are listed in the Key Resource
Table. Data were normalized to the geometrical mean of Actb, 18S and B2 values and quantified using the comparative
2DDCTmethod.
Assays for protein measurements
Insulin concentrations were determined using mouse/rat insulin kits (#K152BZC-1 Mesoscale Discovery) according to the manufac-
turer’s instructions. Mouse IL-1b concentrations in cell supernatants were analyzed using the V-plex mouse IL-1b kit fromMesoscale
Discovery (#K152QPD-1, Alternate Protocol 1, Extended Incubation).
RNA extraction for RNA-Seq
For RNA-Seq experiments, total RNA was isolated from macrophages and monocytes using an adapted protocol based on the
Arcturus PicoPure RNA Isolation Kit method (Applied Biosystems, Thermo Fisher Scientific, USA). Cells were directly sorted into
50 mL extraction buffer supplied in the kit and incubated for 30 min at 42C shaking. Samples were centrifuged at 3,000 x g for
5 min at 4C and supernatants were stored at 80C until further processing. After thawing, equal volumes of 70% (v/v) ethanol
were added to the RNA samples and samples were loaded onto pre-conditioned purification columns. After a washing step, DNase
on-column treatment was performed with the RNase-Free DNase Set (QIAGEN, Germany) to remove residual genomic DNA. For this
purpose, a mix of 5 mL DNase I stock solution and 35 mL RDD buffer was added to the purification column membrane and incubated
for 15min at room temperature. After several washing steps, RNAwas eluted from the column in 15 ml elution buffer. In contrast to this
protocol, total RNA from peritoneal macrophages in the ND-HFD-STZ experiment was extracted using the NucleoSpin RNA isolation
kit (Macherey-Nagel, Germany) according to the manufacturer’s instructions.
Integrity of isolated total RNA was assessed on a 2100 Bioanalyzer System (Agilent Technologies, USA) and RNA concentration
was measured with the Quant-iT RiboGreen RNA Assay Kit (Thermo Fisher Scientific, USA).
Sample preparation and RNA sequencing
Purification of poly(A)-containing mRNA, mRNA fragmentation and cDNA library preparation for RNA-Seq were performed using a
standard Smart-seq2 protocol (Picelli et al., 2014). cDNA libraries from macrophages and monocytes were sequenced as single-
end reads with 125 cycles on a HiSeq2500 sequencer (Illumina, USA) at the Genomics Facility Basel.
Processing of RNA-Seq data
Between 20 and 30 million reads were sequenced per sample. The quality of raw reads was assessed with FastQC (version 0.11.5,
http://www.bioinformatics.babraham.ac.uk/projects/fastqc). SmartSeq2 and Illumina adapters and low quality sequences were
trimmed with Trimmomatic (version 0.36) (Bolger et al., 2014). Trimmed sequences were aligned to the mouse reference genomee5 Cell Reports 30, 1627–1643.e1–e7, February 4, 2020
build GRCm38 (mm10) using STAR (version 2.5.1a) (Dobin et al., 2013) allowing for maximum 5% mismatching bases per read.
Generated alignment (BAM) files were indexed with SAM tools (version 1.4) (Li et al., 2009). Quality of the alignment was evaluated
with Qualimap (version 2.2.1) (Okonechnikov et al., 2016). Reads per gene were counted with the featureCounts function of the Rsu-
bread package (version v1.30.4) (Liao et al., 2014) using gencode versionM13 gene annotation file (https://www.gencodegenes.org).
Reads mapping to multiple sequences were not counted. Raw sequences corresponding to our study as well as count tables of fast-
ing-refeeding and HFD experiments can be retrieved at the NCBI GEO database under accession number GEO: GSE133127
QUANTIFICATION AND STATISTICAL ANALYSIS
General Information
The number of replicates analyzed was: In the transcriptomic analysis: ATM FA: 7, RE: 10, monocytes FA: 8, RE: 9, microglia FA: 8,
RE: 8, colonic macrophages FA: 8, RE: 10, islet macrophages FA: 6, RE: 8, Kupffer cells FA: 6, RE: 7, peritoneal macrophages FA: 8,
RE: 8, islet macrophages HFD: 4, HFD-STZ: 3, ND: 4, peritoneal macrophages HFD: 4, HFD-STZ: 5, ND: 5, microglia HFD: 4, HFD-
STZ: 4, ND: 4. Statistical parameters (reported measures of dispersion and summary measures) can be found in the figure legends.
Statistical assumptions for one-way ANOVA were tested beforehand (normality, homoscedasticity) and found to be met.
Differential expression analysis
Genes with low counts were filtered out using following criteria: after normalization of counts to the library size, only genes with more
than 10 counts in (n-1) of n replicates in at least one experimental group (FA or RE for refeeding experiment or ND, HFD or HFD-STZ
for high-fat diet experiment) were retained. Differential expression analysis was performed in R (version 3.4.1, www.r-project.org)
using DESeq2 (version 1.18.1) and Wald test (Love et al., 2014). Batch information was included in the model and used as a blocking
factor. Batch information can be found in themetadata table (GEO: GSE133127). P values were adjusted to obtain the false discovery
rate (FDR) using the Benjamini & Hochberg method (Benjamini and Hochberg, 1995). Reported log2fold changes were obtained by
shrinkage with lfcShrink default DESeq2 function. For each comparison, two tests were performed: one using a model that included
all data and a contrast for a given comparison and another one with amodel that included only the samples that were compared. This
accounted for different dispersion of macrophage subtype-specific genes and similar dispersion of commonly expressed genes.
Genes passing the adjusted p value threshold of 0.05 in either test were called differentially expressed and used in further analysis.
For differential expression analysis of all RE versus of FA samples in Figure 4, genes with low counts were filtered out using the
following criteria: after normalization of counts to the library size, only genes with more than 10 counts in more than 80% of the sam-
ples were retained. Differential expression analysis was performed with the DESeq2 R package as described above and the macro-
phage subtype was used in the design formula as a blocking factor.
The R packages ggplot2 (version 3.1.0) (Wickham, 2016), pheatmap (version 1.0.12) (Kolde, 2019) and Vennerable (version 3.1.0.9)
(Swinton, 2019) were used for data visualization.
Principal component analysis (PCA)
For PCA in Figures 1C, 1D, and 5B, raw counts were normalized to library size and transformed using the variance stabilizing trans-
formation (vst) function of DESeq2. Only genes with more than 10 counts in more than 80% of the samples were analyzed. The
plotPCA function from the DESeq2 package was used to plot PCA of top 500 variable genes. For Figure 1D, published raw RNA-
Seq data frommicroglia, Kupffer cells, colonic and peritoneal macrophages and monocytes from Lavin et al. (2014) were processed
exactly as our data (two replicates per macrophage subtype). Counts of the samples from the study by Lavin et al. (2014) and our FA
samples from corresponding macrophage subtypes were together normalized to the library size and transformed using the vst func-
tion. Only genes with more than 10 counts in more than 80% of the samples were analyzed. PCA for top 500 variable genes was
plotted.
Gene set and TF motive enrichment
GO term and pathway over-representation analysis were performed used EGSEA (version 1.10.1) (Alhamdoosh et al., 2017) R pack-
age. For pathways analyses, Kegg (https://www.kegg.jp) and MSigDB (http://software.broadinstitute.org/gsea/msigdb/index.jsp)
canonical pathway databases were used. Over-representation analysis by hypergeometric test (implemented in the EGSEA pack-
age) was used for p value calculation with adjustment of p values using the Benjamini & Hochberg method. All expressed genes
as retained after filtering in a given analyzed macrophage subtype or subtypes were used as a background dataset. For Figure 1E,
over-represented GO terms among upregulated genes in each macrophage subtype were sorted based on the adjusted p values.
Top 25 GO terms in each subtype passing the 0.05 adjusted p value threshold were visualized using Enrichment map (version
3.0.0) (Merico et al., 2010) app in Cytoscape software (version 3.7.1) (Shannon et al., 2003). For Figures 2B and 4C, pathways passing
the 0.05 adjusted p-vale threshold were sorted based on the number of DE genes contributing to the over-representation. Top five
(Figure 4C) or top ten (Figure 2B) pathways are displayed. TF motive enrichment analysis was performed using iRegulon (version 1.3)
(Janky et al., 2014) and visualization of putative gene regulatory networks was performed in Cytoscape (version 3.7.1) (Shannon et al.,
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Clustering of genes with correlated expression pattern
To obtain clusters of geneswith correlated expression across ND, HFD andHFD-STZ conditions for each analyzedmacrophage sub-
type, we used the Weighted Gene Correlation Network Analysis (WGCNA) R package (version 1.66) (Langfelder and Horvath, 2008).
DE genes from HFD versus ND and HFD-STZ versus ND comparison were combined and their counts were transformed using vari-
ance stabilizing transformation (vst) DESeq2 function. These were used to construct a signed co-expression network. A soft-
threshold power used to create the pairwise distance matrix was defined as the lowest power for which the scale-free topology
fit index reaches 0.80. Dynamic tree cut (dynamicTreeCut R-package, version 1.63) (Langfelder and Zhang, 2016) was used to define
modules of co-expressed genes. For visualization in Figure 5, mean values of biological replicates in each condition were calculated
for each gene and a relative level (mean subtraction) was displayed. Overlaps between the modules were evaluated using Fisher’s
exact test. GO term analysis was performed by EGSEA R package as described above and representative significantly over-repre-
sented terms from each module are displayed in Figure 5H.
Signature enrichment analysis
To determine which stimuli signatures reported by Xue et al. (2014) are enriched in our data, we followed the methodology described
in Xue et al. (2014). Briefly, mouse genes detected in a givenmacrophage subtype (peritoneal, islet andmicroglia were analyzed) were
translated into their human homologs using Ensembl database queried with biomaRt R package (version 2.38.0) (Durinck et al., 2009)
and sorted based on the differential expression results (-log10 of the adjusted p value multiplied by the sign of the log2fold change).
Sorted lists were used to analyze enrichment of 49 signatures provided by Xue et al. (2014) in Table S2 using GSEA software (version
3.0) (Subramanian et al., 2005) in a pre-ranked, weighted mode.
Analyses of functional and validation studies
For the details of these analyses see figure legends: Figure 3D and Figures S4, S5, S6A–S6C, and S7.
DATA AND CODE AVAILABILITY
All sequencing data newly generated by this study have been deposited at the NCBI’s public functional genomics data repository
Gene Expression Omnibus (The accession number for the dataset reported in this paper is: GEO: GSE133127, processed data
are available on Series record, raw data are available in SRA) andwill bemade available upon publication. The publicly available data-
set used in the paper (Lavin et al., 2014) can be found at GEO: GSE63341. All major software and code used to analyze this dataset
are referenced above.e7 Cell Reports 30, 1627–1643.e1–e7, February 4, 2020
